Although contribution of the differential TME components to patient prognosis remains elusive, our current study proposed that CAF activation represented by COL8A1 in addition to CTL activation reflected by CD8A are critical determinants of prognosis in colon cancers. This evidence concerns the gene COL8A1 and colonic neoplasm.